Oil Gains As Vaccine Hopes Outweigh Lockdown Impact
Brent crude futures rose 34 cents, or 0.8%, to $42.74 by 1312 GMT, while U.S. West Texas Intermediate (WTI) crude futures gained 20 cents, or 0.5%, to $40.49.
Both contracts jumped 8% on Monday, in their biggest daily gains in more than five months, after drugmakers Pfizer and BioNTech said an experimental COVID-19 treatment was more than 90% effective based on initial trial results.
Mass rollouts, however, are likely to be months away and subject to regulatory approvals.
“A viable vaccine is unequivocally game-changing for oil – a market where half of demand comes from moving people and things around,” JP Morgan said in a note.
Prices were also boosted by comments from Saudi Arabia’s energy minister, who said on Monday the Organization of the Petroleum Exporting Countries (OPEC) and its allies, together known as OPEC+, could tweak their supply cut pact if demand slumps before the vaccine is available.
OPEC+ agreed to cut supply by 7.7 million barrels per day from August through December and then ease the cuts by around 2 million bpd in January.
But the negative impact that renewed lockdowns in Europe are having on fuel demand, as well as rising Libyan production, kept prices in check.
Traffic in London, Paris and Madrid fell sharply in November after a peak in October, according to data provided to Reuters by location technology company TomTom, that covered mobility until Sunday evening.
France, the United Kingdom, Spain and Poland were under the strictest lockdowns in Europe, according to the Oxford stringency index that assesses indicators such as school and workplace closures, and travel bans.
Meanwhile Libyan production has risen above 1 million bpd in recent days from 100,000 bpd in early September.
Goldman Sachs lowered its first quarter 2021 Brent price forecast to $47 per barrel from $51 per barrel. The bank trimmed its WTI crude price forecast to $52.80 a barrel from $55.90 a barrel.
(Additional reporting by Sonali Paul and Seng Li Peng; Editing by Susan Fenton, Kirsten Donovan)
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor